Envista Holdings Corporation (NVST)

Market Cap	3.29B
Revenue (ttm)	2.56B
Net Income (ttm)	-120.40M
Shares Out	171.86M
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	12.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,221,967
Open	19.14
Previous Close	18.86
Day's Range	18.96 - 19.47
52-Week Range	18.09 - 36.14
Beta	1.35
Analysts	Hold
Price Target	25.41 (+32.55%)
Earnings Date	May 1, 2024

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 18, 2019
• Employees: 12,800
• Stock Exchange: NYSE
• Ticker Symbol: NVST

Analyst Forecast

According to 13 analysts, the average rating for NVST stock is "Hold." The 12-month stock price forecast is $25.41, which is an increase of 32.55% from the latest price.

Price Target

$25.41

(32.55% upside)

Analyst Consensus: Hold